This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
TNNI3 / Troponin I, cardiac muscle · IHC design guide
Design Immunohistochemistry for TNNI3
Plan chromogenic IHC on paraffin sections using heart muscle as a positive tissue control: cardiomyocytes show high cytoplasmic staining (HPA tissue IHC). Testis pachytene spermatocytes also show medium staining, so interpret staining outside the heart in context (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
TNNI3 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Cytoplasm of cardiac myocytes (HPA tissue IHC) | |
| Staining pattern | Cytoplasmic staining in cardiac myocytes (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6.0 HIER, 95–98 °C, 20 min (rule: cytoplasmic / membrane antigen) | |
| Positive control | Heart muscle+1 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Keep paraffin-section fixation consistent across samples. (standard IHC practice; not target-specific) | |
| Caveat | Pachytene spermatocytes also show medium staining (HPA tissue IHC) | |
| Regulation | Heart muscle enriched at RNA level (HPA tissue RNA) | |
| Isoform / epitope | 0 isoforms annotated; mature chain spans aa 2–210 (UniProt) |
Section 1
Recommended TNNI3 IHC & IF Protocols
The catalog antibody’s IHC-P protocol is paired with published protocols for mouse heart sections (PMC3376223) and mouse lung sections (PMC5592927).
| Sample | Tissue sections; selected-image fixative not specified (standard IHC workflow) |
| Fixation | Image fixative and duration unreported (datasheet M01720-3); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat-induced epitope retrieval in citrate buffer, pH 6.0, 20 min at 95–98 °C (standard rule: cytoplasmic / membrane antigen) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% normal serum of the secondary host, 30 min, room temperature (standard) |
| Primary antibody | Rabbit anti-TNNI3, 1:200-1:1000 (datasheet M01720-3) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | TNNI3-positive staining in cardiomyocytes of heart muscle (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in cardiac myocytes. No signal in the no-primary control. |
💡Decision noteStart with citrate pH 6.0 HIER at 95–98 °C for 20 min (page retrieval); the lung study used TBS/EDTA pH 9.0 (PMC5592927).
Section 2
What Is the Expected TNNI3 Staining Pattern?
In paraffin-section IHC, expect TNNI3 staining in the cytoplasm of cardiomyocytes, with strong signal in heart muscle (HPA: cytoplasmic expression in cardiac myocytes; High in cardiomyocytes). HPA rates the tissue pattern Enhanced, citing high consistency between antibody staining and RNA expression (HPA: tissue IHC reliability). UniProt describes TNNI3 as a thin-filament regulatory protein without a transmembrane segment, but provides no subcellular localization annotation (UniProt P19429: function, topology, subcellular record).
| Strong cytoplasmic staining in cardiomyocytes, concentrated in the expected heart-muscle cells. | This matches the reported IHC pattern and is the clearest positive readout (HPA: cytoplasmic expression in cardiac myocytes; High in cardiomyocytes). Assess the stained cells and compartment together; color intensity alone does not establish that a result is specific (standard IHC interpretation). |
| Predominantly nuclear or cell-surface staining in cardiomyocytes, with little cytoplasmic signal. | Treat this as a compartment mismatch that warrants review for artefact or nonspecific detection (HPA: cytoplasmic cardiac-myocyte IHC; UniProt P19429: no transmembrane segment). UniProt does not supply a subcellular annotation, so its topology cannot independently define the microscopic pattern (UniProt P19429: subcellular record, topology). |
| Strong staining in cells expected to be negative, such as adipocytes in adipose tissue. | Consider antibody cross-reactivity or endogenous chromogenic detection activity (HPA: TNNI3 not detected in adipose-tissue adipocytes; standard IHC practice). A negative-tissue comparison and appropriate detection control can help distinguish these possibilities; an unexpected stain is not proof of either cause (standard IHC practice). |
| Diffuse color across tissue, extracellular spaces, or multiple unrelated cell types. | This obscures the cell-restricted pattern reported in heart muscle (HPA: High in cardiomyocytes). Uneven blocking, residual detection background, or overly concentrated reagents are general IHC possibilities; evaluate them with controls before assigning the color to TNNI3 (standard IHC practice). |
| No convincing cytoplasmic staining in a heart-muscle section that should be positive. | Target-specific fixation effects are not established by the supplied assay evidence. Verify with a matched IHC source before attributing a result to fixation. |
💡Expected TNNI3 appearanceCall a section positive when cardiomyocytes show strong cytoplasmic chromogenic staining (HPA: High in heart-muscle cardiomyocytes; cytoplasmic IHC); widespread nuclear, cell-surface, or negative-tissue staining instead calls for review of specificity or detection background (HPA: cardiac-myocyte pattern and negative tissues; standard IHC interpretation).
| Which tissue and cells anchor the IHC call? | Heart-muscle cardiomyocytes are the strongest supplied reference (HPA: High). Testis pachytene spermatocytes have Medium staining, so positivity outside heart muscle is not automatically false; judge each cell type against its own HPA observation (HPA: Medium in testis pachytene spermatocytes). Several other listed tissues are not detected, including adipose tissue and adrenal gland (HPA: tissue IHC). |
| How much confidence does the antibody evidence provide? | The reported tissue pattern has Enhanced reliability because antibody staining is highly consistent with RNA expression (HPA: tissue IHC reliability). HPA lists Enhanced IHC status for HPA046428 and CAB009349 (HPA: antibody validation). This supports the reference pattern, while an individual section still needs sound controls and cell-level review (standard IHC interpretation). |
| Does topology predict a membrane stain? | UniProt reports no transmembrane segment and identifies TNNI3 as the inhibitory subunit of the thin-filament troponin complex (UniProt P19429: topology, function). Use the observed cytoplasmic cardiomyocyte pattern for the IHC decision (HPA: tissue IHC). Neither statement identifies a target-specific antigen-retrieval condition or fixation response (UniProt P19429; HPA tissue IHC). |
| What should IF/ICC show? | For an IF/ICC image, HPA reports mainly cytosolic localization with additional vesicular localization (HPA: approved cytosol and vesicles in ICC-IF). That observation can inform compartment review, but it comes from ICC-IF rather than paraffin-section chromogenic IHC; use the cardiac-myocyte tissue result as the IHC reference (HPA: subcellular ICC-IF; tissue IHC). |
| Situation | Likely cause | Next action |
|---|---|---|
| Heart-muscle cardiomyocytes show no stain. | The result misses the reported High positive reference; a workflow failure is possible (HPA: High in cardiomyocytes; standard IHC practice). | Target-specific fixation effects are not established by the supplied assay evidence. Verify with a matched IHC source before attributing a result to fixation. |
| The heart section is stained, but nuclei dominate. | The compartment differs from the reported cytoplasmic IHC pattern (HPA: cytoplasmic cardiac-myocyte expression). | Compare cell boundaries and counterstain with the chromogen distribution; review background and antibody specificity using controls before scoring the nuclei as TNNI3-positive (standard IHC practice). |
| Adipocytes or other listed negative cells stain strongly. | This disagrees with the applicable HPA negative-cell observation and may reflect cross-reactivity or endogenous detection activity (HPA: adipocytes not detected; standard IHC practice). | Compare a negative tissue and a no-primary detection control; if background persists, review blocking and chromogenic detection conditions (standard IHC practice). Interpret testis separately because pachytene spermatocytes are Medium (HPA: testis). |
| Color is diffuse across the section. | Broad color makes the expected cardiac-myocyte cytoplasmic pattern difficult to resolve (HPA: tissue IHC); detection background is possible (standard IHC practice). | Inspect the no-primary control and reagent handling, then optimize general blocking, washes, or antibody concentration as indicated by those controls (standard IHC practice). |
| Only a few heart-muscle cells appear positive. | Patchiness may reflect section quality or uneven staining rather than the expected High cardiomyocyte pattern (HPA: High in heart-muscle cardiomyocytes; standard IHC practice). | Check morphology across the section and whether retrieval, antibody coverage, and chromogen development were uniform; compare with a well-stained positive control (standard IHC practice). |
| IF/ICC seems vesicular while the tissue IHC call is cytoplasmic. | HPA reports additional vesicular ICC-IF localization alongside its main cytosolic signal (HPA: subcellular ICC-IF). | Interpret each application against its own evidence: review the IF/ICC compartment against HPA subcellular data and score paraffin-section IHC against cytoplasmic cardiomyocytes (HPA: subcellular ICC-IF; tissue IHC). |
Experiment evidence
IHC & IF images showing TNNI3 staining
M01720-3 · IHCMouse cardiac muscle was stained with anti-Cardiac Troponin I rabbit antibody
M01720-3 · IHCRat cardiac muscle was stained with anti-Cardiac Troponin I rabbit antibody
M01720 · IHCImmunohistochemical analysis of paraffin-embedded human heart, using Troponin I Antibody.
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000129991-TNNI3/tissue/cerebral+cortex#imid_17610426
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000129991-TNNI3/tissue/colon#imid_17604169
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000129991-TNNI3/tissue/liver#imid_17604162
HPA · KidneyHuman Protein Atlas IHC, Kidney. Source: https://www.proteinatlas.org/ENSG00000129991-TNNI3/tissue/kidney#imid_17604171
HPA · ICC-IF HEK293Human Protein Atlas immunofluorescence, HEK293, antibody HPA046428; green = TNNI3, blue = nucleus, red = microtubules.
HPA · ICC-IF HEK293Human Protein Atlas immunofluorescence, HEK293, antibody HPA046428; green = TNNI3, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for TNNI3 IHC & IF
🧪Run heart muscle first: cardiomyocytes should stain strongly (HPA: High in cardiomyocytes). Use adipose tissue as a negative comparator (HPA: Not detected in adipocytes); noncardiomyocyte cells on the heart section should show little or no specific staining relative to cardiomyocytes (HPA: High in cardiomyocytes).
Positive control tissue: Heart muscle (Cardiomyocytes, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show TNNI3 in HEK293, SH-SY5Y, U2OS, with annotated localisation: Cytosol (approved) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control and an isotype control matched to the primary antibody’s host species and monoclonal or polyclonal format; the captioned primary is rabbit (selected IHC caption: rabbit antibody). Use TNNI3 knockout tissue as a biological negative where available, and quench endogenous peroxidase in heart sections for chromogenic detection (standard IHC practice).
⚠️Feasibility: No target-specific fixation window or fixation effect is reported in the supplied evidence; the selected SKU M01720-3 tissue-IHC caption does not report a fixative (selected IHC caption: fixative not stated). Antigen retrieval dependence is unreported, and the evidence does not establish whether frozen sections or IF are easier than paraffin IHC. Check heart sections for endogenous peroxidase background when interpreting chromogenic staining (standard IHC practice).
HPA tissue IHC evidence for TNNI3
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Enhanced — High consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Heart muscle | Cardiomyocytes | High | Protein (IHC) | HPA → |
| Testis | Pachytene spermatocytes | Medium | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced TNNI3 IHC Tips
Use cardiac myocyte staining as the reference pattern while optimising paraffin-section IHC for TNNI3 (HPA tissue IHC).
Which retrieval conditions should I try first for weak TNNI3 staining in paraffin sections?
Start with citrate buffer at pH 6.0 for heat-induced retrieval at 95–98 °C for 20 minutes (page retrieval setting). Let sections cool in the retrieval buffer before washing, and process the heart-muscle control alongside experimental sections (standard IHC practice; HPA tissue IHC). If staining remains weak, compare a longer retrieval time or an alternative buffer on adjacent sections while holding detection conditions constant (standard IHC practice). Excessive retrieval can damage tissue morphology, so assess preservation as well as signal (standard IHC practice). Score cytoplasmic staining in cardiomyocytes when judging the result (HPA tissue IHC).
Could fixation explain weak or uneven TNNI3 staining?
Target-specific fixation sensitivity is unknown: the selected M01720-3 cardiac-muscle caption does not report its fixative (caption M01720-3). Record each block’s fixative and fixation duration, then compare experimental sections with a heart-muscle control processed under the same conditions (standard IHC practice; HPA tissue IHC). Uneven staining can also reflect differences in section handling, retrieval, or detection, so change one variable at a time (standard IHC practice). Check tissue integrity and staining across the full section before adjusting retrieval (standard IHC practice). Do not assign a TNNI3-specific fixation effect from its phosphorylation sites or tissue expression pattern (UniProt P19429; HPA tissue IHC).
Where should convincing TNNI3 staining appear in cardiac tissue?
Assess staining within cardiac myocytes, where the tissue IHC profile reports cytoplasmic expression (HPA tissue IHC). TNNI3 functions in the thin-filament troponin complex and binds actin and tropomyosin, providing context for a myocyte-associated pattern (UniProt P19429). Compare the distribution with tissue morphology and counterstain; isolated nuclear staining should prompt review of background and detection controls (standard IHC practice; HPA tissue IHC). HPA separately reports cytosol as the main subcellular location and vesicles as an additional location in its subcellular dataset (HPA subcellular). Those observations do not establish a required vesicular pattern for this chromogenic tissue assay (HPA subcellular; standard IHC practice).
Could epitope choice or phosphorylation change the IHC result?
The supplied UniProt record lists 0 isoforms, but that alone does not establish what the catalog antibody recognises (UniProt P19429). TNNI3 has annotated modified residues, including phosphorylation at positions 23 and 24 by PKA and PKD/PRKD1 (UniProt P19429). Without an epitope map or direct testing, do not attribute staining differences to those modifications (UniProt P19429; standard IHC practice). Compare adjacent sections using the same retrieval and detection conditions, and document the antibody identity for reproducibility (standard IHC practice). If an epitope-specific interpretation is essential, verify it with independently characterised material before assigning biological meaning to intensity changes (standard IHC practice).
How should I evaluate TNNI3 in a multiplex IF experiment?
Pair TNNI3 with a marker identifying the expected cardiomyocytes and assess signal within the same cells (HPA tissue IHC; standard IF practice). Choose fluorophores after inspecting unstained tissue for autofluorescence, and use single-colour controls to check channel bleed-through (standard IF practice). TNNI3 has no annotated transmembrane segment, while HPA reports a mainly cytosolic location, so use permeabilisation suitable for an intracellular epitope and confirm it preserves morphology (UniProt P19429; HPA subcellular; standard IF practice). Record fixation and permeabilisation conditions during optimisation because the supplied product caption reports neither an IF method nor a fixative (caption M01720-3). Treat IF performance of this catalog antibody as unestablished until tested directly (caption M01720-3).
How can I distinguish diffuse background from genuine TNNI3 staining?
Run a no-primary control and a heart-muscle positive control through the same chromogenic detection sequence (standard IHC practice; HPA tissue IHC). For a peroxidase and DAB workflow, a 3% hydrogen peroxide block for about 10 minutes is a general way to assess endogenous peroxidase contribution (standard IHC practice). Adjust blocking and washing if diffuse deposit persists, while keeping comparison sections under matched conditions (standard IHC practice). Use tissue morphology to judge whether signal lies in cardiac myocytes rather than damaged edges or debris (HPA tissue IHC; standard IHC practice). A negative-control tissue can help, but absence of staining is meaningful only after adequate tissue and assay controls (standard IHC practice).
What should I measure when comparing TNNI3 IHC across sections? ⚠ ANSWER MARKED FOR VERIFICATION
Define viable cardiomyocytes as the scoring population because HPA reports cytoplasmic expression in those cells (HPA tissue IHC). For an H-score, grade cytoplasmic intensity from 0 to 3 and sum each grade multiplied by its percentage of scored cells, giving 0–300 (standard IHC practice). Alternatively, report the percentage of positive cardiomyocytes using a prespecified threshold, with the number of evaluable cells or tissue area recorded (standard IHC practice). Normalise comparisons to viable cardiomyocyte count or viable myocyte area, and exclude damaged or necrotic regions consistently (standard IHC practice). Keep retrieval, imaging, counterstain, and scoring thresholds matched across batches (standard IHC practice).
Which patterns would make a TNNI3-positive result doubtful?
A convincing result places signal in cardiac-myocyte cytoplasm and agrees with the heart-muscle enrichment reported by HPA (HPA tissue IHC). Predominantly nuclear signal, strong staining in an unexpected cell population, or deposit confined to section edges should trigger review of morphology and controls (HPA tissue IHC; standard IHC practice). Necrotic tissue and endogenous enzyme activity can create misleading chromogenic deposits, so inspect matched no-primary and peroxidase-block controls (standard IHC practice). HPA also reports medium staining in testis pachytene spermatocytes, so expression outside heart muscle cannot be dismissed solely by tissue name (HPA tissue IHC). Interpret intensity changes only after checking section quality and matched processing (standard IHC practice).
Boster reagents
Best TNNI3 / Troponin I, cardiac muscle IHC Antibodies
Anti-TNNI3 antibodies have IHC images from human heart paraffin sections and mouse and rat cardiac muscle (catalog IHC captions). Both list IF, but neither supplies an IF image (catalog applications and image alts).
Real IHC data
Anti-Cardiac Troponin I Rabbit Monoclonal Antibody
Cat # M01720-3
Real IHC data
Anti-Troponin I Rabbit Monoclonal Antibody
Cat # M01720
M01720 lists human IHC, IF and ICC, with an IHC image of paraffin-embedded human heart (catalog applications, reactivity and IHC caption). M01720-3 lists human, mouse and rat IHC and IF, with IHC images of mouse and rat cardiac muscle (catalog applications, reactivity and IHC captions).
Which to pick: For human paraffin-section IHC, choose monoclonal M01720: its own IHC image shows paraffin-embedded human heart; the fixative is unreported (catalog clone and IHC caption). For IF/ICC, M01720 lists both applications for human samples, while monoclonal M01720-3 lists IF for human, mouse and rat samples (catalog applications, reactivity and antibody descriptions). For cross-species tissue IHC, choose M01720-3: its own IHC images show mouse and rat cardiac muscle, and human reactivity is listed; section processing and fixative are unreported in those captions (catalog reactivity and IHC captions).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P19429 (TNNI3_HUMAN, Troponin I, cardiac muscle).
- Human Protein Atlas. TNNI3 tissue IHC expression (reliability: Enhanced).
- Human Protein Atlas. TNNI3 subcellular location (ICC-IF): Mainly localized to the cytosol. In addition localized to vesicles..
- Human Protein Atlas. TNNI3 antibody validation summary (2 antibodies).
- Targeting native adult heart progenitors with cardiogenic small molecules. ACS chemical biology 2012 — PMC3376223.
- Bioinformatic analysis of membrane and associated proteins in murine cardiomyocytes and human myocardium. Scientific data 2020 — PMC7708497.
- Gene Expression Networks in the Murine Pulmonary Myocardium Provide Insight into the Pathobiology of Atrial Fibrillation. G3 (Bethesda, Md.) 2017 — PMC5592927.
- PubMed PMID:2226790 — UniProt-cited evidence.
- PubMed PMID:8406024 — UniProt-cited evidence.
- PubMed PMID:1934363 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for TNNI3 (Troponin I, cardiac muscle). Expected localisation Cytoplasm of cardiac myocytes (HPA tissue IHC). Antigen retrieval: Citrate pH 6.0 HIER, 95–98 °C, 20 min (rule: cytoplasmic / membrane antigen). Validated IHC antibody: M01720-3 at 1:200-1:1000 (the product's own IHC validation image is shown). Controls (HPA): positive Heart muscle (Cardiomyocytes); negative Adipose tissue. IHC workflow; specimen preparation unspecified. Protocol steps: 1. Sample: Tissue sections; selected-image fixative not specified (standard IHC workflow); 2. Fixation: Image fixative and duration unreported (datasheet M01720-3); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat-induced epitope retrieval in citrate buffer, pH 6.0 , 20 min at 95–98 °C…; 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% normal serum of the secondary host, 30 min , room temperature (standard); 8. Primary antibody: Rabbit anti-TNNI3, 1:200-1:1000 (datasheet M01720-3); 9. Primary incubation: Overnight at 4 °C (standard). Watch for: Fixation: Keep paraffin-section fixation consistent across samples. (standard IHC practice; not target-specific); Caveat: Pachytene spermatocytes also show medium staining (HPA tissue IHC); Isoform / epitope: 0 isoforms annotated; mature chain spans aa 2–210 (UniProt); Regulation: Heart muscle enriched at RNA level (HPA tissue RNA). Evidence: UniProt P19429, HPA tissue IHC · Enhanced, HPA ICC-IF · Mainly localized to the cytosol. In addition localized to vesicles., Datasheet M01720-3, PMC3376223, PMC5592927. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/TNNI3/immunohistochemistry-ihc-guide.